Cargando…

Metabolomics of blood reveals age-dependent pathways in Parkinson’s Disease

BACKGROUND: Parkinson’s Disease (PD) is the second most frequent degenerative disorder, the risk of which increases with age. A preclinical PD diagnostic test does not exist. We identify PD blood metabolites and metabolic pathways significantly correlated with age to develop personalized age-depende...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Ascenzo, Nicola, Antonecchia, Emanuele, Angiolillo, Antonella, Bender, Victor, Camerlenghi, Marco, Xie, Qingguo, Di Costanzo, Alfonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258166/
https://www.ncbi.nlm.nih.gov/pubmed/35794650
http://dx.doi.org/10.1186/s13578-022-00831-5
Descripción
Sumario:BACKGROUND: Parkinson’s Disease (PD) is the second most frequent degenerative disorder, the risk of which increases with age. A preclinical PD diagnostic test does not exist. We identify PD blood metabolites and metabolic pathways significantly correlated with age to develop personalized age-dependent PD blood biomarkers. RESULTS: We found 33 metabolites producing a receiver operating characteristic (ROC) area under the curve (AUC) value of 97%. PCA revealed that they belong to three pathways with distinct age-dependent behavior: glycine, threonine and serine metabolism correlates with age only in PD patients; unsaturated fatty acids biosynthesis correlates with age only in a healthy control group; and, finally, tryptophan metabolism characterizes PD but does not correlate with age. CONCLUSIONS: The targeted analysis of the blood metabolome proposed in this paper allowed to find specific age-related metabolites and metabolic pathways. The model offers a promising set of blood biomarkers for a personalized age-dependent approach to the early PD diagnosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13578-022-00831-5.